Best practices to operationalize AI and automation in PV
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
In this on-demand session, join leaders from Bristol Myers Squibb, Accenture, and ArisGlobal for an engaging webinar panel discussion.
In our checklist, we outline the most important criteria that leading firms are keeping in mind to get the most out of AI and automation.
We outline what you should look for when evaluating modular enhancements to your PV ecosystem and finding a partner that can support your unique digital transformation goals.
Check out our whitepaper to learn about our novel Case Completeness Score framework, including its development, real-world applications, and the unprecedented signaling efficiencies it delivers.
Explore how regulatory teams are leveraging GenAI and advanced automation to streamline operations, increase precision, and stay compliant.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved